Meta-analysis of the association between long Non-coding RNA-PVT1 expression and the prognosis and clinicopathology of digestive system malignant tumors #br#
Abstract：School, Shanxi Medical University, Shanxi Province, Taiyuan 030001, China; 2.Department of General Surgery, Second Hospital of Shanxi Medical University, Shanxi Province, Taiyuan 030001, China
[Abstract] Objective To study the relationship between long non coding RNA-plasmacytoma variant translocation 1 （PVT1) and the clinicopathological features and prognosis of digestive system malignancies. Methods The Web of Science, EMBASE, and PubMed were searched, the search ended on January 2021. According to the retrieval strategy and inclusion and exclusion criteria, the literatures were screened and the relevant data were extracted. RevMan v5.3 software was used for meta analysis. Results A total of 32 studies involving 2873 patients were included. The highly expressed PVT1 levels were potentially connected with poorer overall survival (HR = 1.71, 95%CI:1.54-1.89, P ＜ 0.000 01) and disease free survival (HR = 1.95, 95%CI:1.67-2.29, P ＜ 0.000 01). Highly expressed PVT1 levels were also positively correlated with diameter of tumor (OR = 2.02, 95%CI: 1.43-2.86, P ＜ 0.000 01)，TNM stage （OR = 3.42, 95%CI: 2.86-4.08, P ＜ 0.000 01), lymph node metastasis (OR = 3.04, 95%CI:2.41-3.84, P ＜ 0.000 01), tumor differentiation (OR = 1.81, 95%CI:1.21-2.72, P = 0.004), distant metastasis (OR = 2.91, 95%CI:2.06-4.11, P ＜ 0.000 01) and infiltration depth (OR = 5.19, 95%CI:3.52-7.66, P ＜ 0.000 01). Conclusion PVT1 can be used to gauge clinicopathological characteristics and outcomes in patients withdigestive system malignant tumors.
刘莹涛1 方昌中2 陈文亮2. 长链非编码RNA-PVT1表达与消化系统恶性肿瘤预后及临床病理关系的meta分析[J]. 中国医药导报, 2021, 18(29): 106-111.
LIU Yingtao1 FANG Changzhong2 CHEN Wenliang2. Meta-analysis of the association between long Non-coding RNA-PVT1 expression and the prognosis and clinicopathology of digestive system malignant tumors #br#. 中国医药导报, 2021, 18(29): 106-111.
[1] Siegel RL，Miller KD，Jemal A. Cancer statistics，2019 [J]. CA Cancer J Clin，2019，69（1）：37-34.
[2] Ding J，Li D，Gong M，et al. Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer [J]. Onco Targets Ther，2014，7：1625-1630.
[3] Kong R，Zhang EB，Yin DD，et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16 [J]. Mol Cancer，2015，14：82.
[4] Yuan CL，Li H，Zhu L，et al. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer [J]. Neoplasma，2016，63（3）：442-449.
[5] Xu MD，Wang Y，Weng W，et al. A Positive Feedback Loop of lncRNA-PVT1 and FOXM1 Facilitates Gastric Cancer Growth and Invasion [J]. Clin Cancer Res，2017， 23（8）：2071-2080.
[6] Chen J，Li Y，Zheng Q，et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer [J]. Cancer Lett，2017，388：208-219.
[7] Huang T，Liu HW，Chen JQ，et al. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer [J]. Biomed Pharmacother，2017，88：302-308.
[8] Ren X，Cao D，Yang L，et al. High Expression of long non-coding RNA PVT1 predicts metastasis in Han and Uygur Patients with Gastric Cancer in Xinjiang [J]. China Sci Rep，2019，9（1）：548.
[9] Zhao S，Fan NF，Chen XH，et al. Long noncoding RNA PVT1-214 enhances gastric cancer progression by upregulating TrkC expression in competitively sponging way [J]. Eur Rev Med Pharmacol Sci，2019，23（10）：4173-4184.
[10] Niu J，Song X，Zhang X. Regulation of lncRNA PVT1 on miR-125 in metastasis of gastric cancer cells [J]. Oncol Lett，2020，19（2）：1261-1266.
[11] Takahashi Y，Sawada G，Kurashige J，et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers [J]. Br J Cancer，2014，110（1）：164-171.
[12] He F，Song Z，Chen H，et al. Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128 [J]. Oncogen，2019，38（2）：164-179.
[13] Ping G，Xiong W，Zhang L，et al. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer [J]. Am J Transl Res，2018， 10（1）：138-149.
[14] Fan H，Zhu JH，Yao XQ. Long non-coding RNA PVT1 as a novel potential biomarker for predicting the prognosis of colorectal cancer [J]. Int J Biol Markers，2018，33（4）：415-422.
[15] Yu X，Zhao J，He Y. Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p/RUNX2 axis [J]. J BuoN，2018，23（1）：48-54.
[16] Wang Z，Su M，Xiang B，et al. Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC [J]. Biochem Biophys Res Commun，2019，512（4）：716-722.
[17] Wu H，Wei M，Jiang X，et al. lncRNA PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing miR-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis [J]. Mol Ther Nucleic Acids，2020，20：438-450.
[18] Wang F，Yuan JH，Wang SB，et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2 [J]. Hepatology，2014，60（4）：1278-1290.
[19] Ding C，Yang Z，Lv Z，et al. Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients [J]. Oncol Lett，2015，9（2）：955-963.
[20] Gou X，Zhao X，Wang Z. Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214 [J]. Cancer Biomark，2017，20（4）：511-519.
[21] Lan T，Yan X，Li Z，et al. Long non-coding RNA PVT1 serves as a competing endogenous RNA for miR-186-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma [J]. Tumour Biol，2017，39（6）：10104 28317705338
[22] Guo J，Hao C，Wang C，et al. Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2 [J]. Cancer Cell Int，2018， 18：98.
[23] Zhu Y，Liu Y，Xiao B，et al. The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma [J]. Biol Open，2019，8（9）：bio043687.
[24] Yang L，Peng X，Jin H，et al. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma [J]. Gene，2019，697：94-102.
[25] Huang C，Yu W，Wang Q，et al. Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients [J]. Minerva Med，2015，106（3）：143-149.
[26] Zhao L，Kong H，Sun H，et al. LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448 [J]. J Cell Physiol，2018，233（5）：4044-4055.
[27] Wu BQ，Jiang Y，Zhu F，et al. Long Noncoding RNA PVT1 Promotes EMT and Cell Proliferation and Migration Thr-ough Downregulating p21 in Pancreatic Cancer Cells [J]. Technol Cancer Res Treat，2017，16（6）：819-827.
[28] Huang F，Chen W，Peng J，et al. LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis [J]. Mol Cancer，2018，17（1）：98.
[29] Sun J，Zhang P，Yin T，et al. Upregulation of LncRNA PVT1 Facilitates Pancreatic Ductal Adenocarcinoma Cell Progression and Glycolysis by Regulating MiR-519d-3p and HIF-1A [J]. J Cancer，2020，11（9）：2572-2579.
[30] Zheng X，Hu H，Li S. High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer [J]. Oncol Lett，2016，12（4）：2357-2362.
[31] Li PD，Hu JL，Ma C，et al. Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1 [J]. Oncotarget，2017，8（21）：34164-34176.
[32] Xu Y，Li Y，Jin J，et al. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma [J]. Mol Cancer，2019，18（1）：141.
[33] Shen SN，Li K，Liu Y，et al. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1 [J]. Mol Oncol，2019，13（12）：2554-2573.
京公网安备 11010502046598号